Lista de obras -

Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines

artículo científico publicado en 2011

Bacterial infection in scarring trachoma

artículo científico publicado en 2011

Chlamydial positivity of nasal discharge at baseline is associated with ocular chlamydial positivity 2 months following azithromycin treatment.

artículo científico publicado en 2006

Differential frequency of NKG2C/KLRC2 deletion in distinct African populations and susceptibility to Trachoma: a new method for imputation of KLRC2 genotypes from SNP genotyping data

artículo científico publicado en 2016

DjinniChip: evaluation of a novel molecular rapid diagnostic device for the detection of Chlamydia trachomatis in trachoma-endemic areas

artículo científico publicado en 2020

Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study.

scientific article published on May 2006

Immunofibrogenic Gene Expression Patterns in Tanzanian Children with Ocular Chlamydia trachomatis Infection, Active Trachoma and Scarring: Baseline Results of a 4-Year Longitudinal Study

artículo científico publicado en 2017

Immunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative Cells

artículo científico publicado en 2016

Immunopathogenesis of Progressive Scarring Trachoma: Results of a 4-Year Longitudinal Study in Tanzanian Children

scientific article published on 23 March 2020

In vivo confocal microscopy and histopathology of the conjunctiva in trachomatous scarring and normal tissue: a systematic comparison

artículo científico publicado en 2013

In vivo confocal microscopy in scarring trachoma

artículo científico publicado en 2011

In vivo confocal microscopy of trachoma in relation to normal tarsal conjunctiva.

artículo científico publicado en 2010

Innate immune responses and modified extracellular matrix regulation characterize bacterial infection and cellular/connective tissue changes in scarring trachoma.

artículo científico publicado en 2011

Mass treatment with single-dose azithromycin for trachoma.

artículo científico publicado en 2004

Non-Chlamydial Bacterial Infection and Progression of Conjunctival Scarring in Trachoma.

artículo científico publicado en 2018

Pathogenesis of progressive scarring trachoma in Ethiopia and Tanzania and its implications for disease control: two cohort studies

artículo científico publicado en 2015

Reduced-cost Chlamydia trachomatis-specific multiplex real-time PCR diagnostic assay evaluated for ocular swabs and use by trachoma research programmes.

scientific article published on 06 May 2017

Serology for trachoma surveillance after cessation of mass drug administration

artículo científico publicado en 2015

Strategies for control of trachoma: observational study with quantitative PCR.

scientific article published on July 2003

The utility of serology for elimination surveillance of trachoma

scientific article published in Nature Communications

Two doses of azithromycin to eliminate trachoma in a Tanzanian community.

artículo científico publicado en 2008

What is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence setting

artículo científico publicado en 2011

miRNAs that associate with conjunctival inflammation and ocular Chlamydia trachomatis infection do not predict progressive disease

artículo científico publicado en 2017

Lista de obras de

Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines

Bacterial infection in scarring trachoma

Chlamydial positivity of nasal discharge at baseline is associated with ocular chlamydial positivity 2 months following azithromycin treatment.

Differential frequency of NKG2C/KLRC2 deletion in distinct African populations and susceptibility to Trachoma: a new method for imputation of KLRC2 genotypes from SNP genotyping data

DjinniChip: evaluation of a novel molecular rapid diagnostic device for the detection of Chlamydia trachomatis in trachoma-endemic areas

Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study.

Immunofibrogenic Gene Expression Patterns in Tanzanian Children with Ocular Chlamydia trachomatis Infection, Active Trachoma and Scarring: Baseline Results of a 4-Year Longitudinal Study

Immunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative Cells

Immunopathogenesis of Progressive Scarring Trachoma: Results of a 4-Year Longitudinal Study in Tanzanian Children

In vivo confocal microscopy and histopathology of the conjunctiva in trachomatous scarring and normal tissue: a systematic comparison

In vivo confocal microscopy in scarring trachoma

In vivo confocal microscopy of trachoma in relation to normal tarsal conjunctiva.

Innate immune responses and modified extracellular matrix regulation characterize bacterial infection and cellular/connective tissue changes in scarring trachoma.

Mass treatment with single-dose azithromycin for trachoma.

Non-Chlamydial Bacterial Infection and Progression of Conjunctival Scarring in Trachoma.

Pathogenesis of progressive scarring trachoma in Ethiopia and Tanzania and its implications for disease control: two cohort studies

Reduced-cost Chlamydia trachomatis-specific multiplex real-time PCR diagnostic assay evaluated for ocular swabs and use by trachoma research programmes.

Serology for trachoma surveillance after cessation of mass drug administration

Strategies for control of trachoma: observational study with quantitative PCR.

The utility of serology for elimination surveillance of trachoma

Two doses of azithromycin to eliminate trachoma in a Tanzanian community.

What is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence setting

miRNAs that associate with conjunctival inflammation and ocular Chlamydia trachomatis infection do not predict progressive disease